Trial · NCT07892105
Effects of Manual Lymphatic Drainage and Pressotherapy on Muscle Recovery After Eccentric Exercise in Physically Active Young Adults
NCT07892105, Not applicable, Not yet recruiting, Camilo Jose Cela University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Manual Lymphatic Drainage and Pressotherapy on Muscle Recovery After Eccentric Exercise in Physically Active Young Adults. Trials, record NCT07892105. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892105
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Manual Lymphatic Drainage and Pressotherapy on Muscle Recovery After Eccentric Exercise in Physically Active Young Adults
- NCT number
- NCT07892105
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 20 participants, estimated
- Lead sponsor
- Camilo Jose Cela University
- Conditions
- Young Athletes
- Interventions
- Manual Lymphatic Drainage, Intermittent Pheumatic Compression
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Blood Lactate Concentration | Baseline, immediately post-exercise, 3 minutes post-exercise, 10 minutes post-exercise, and immediately after the recovery intervention | Blood lactate concentration (mmol/L) measured from capillary blood samples using a portable lactate analyzer. Changes in lactate concentration will be used to assess metabolic recovery following exercise-induced muscle damage. |
| Primary | Change in Countermovement Jump Performance | Baseline, immediately post-exercise, immediately after the recovery intervention, 24 hours, 3 days, and 7 days after exercise. | Countermovement jump (CMJ) height, measured in centimeters using a validated jump assessment system. Changes in jump performance will be used as an indicator of neuromuscular recovery and lower-limb functional capacity. |
| Secondary | Delayed-Onset Muscle Soreness (DOMS) | Baseline, immediately post-exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise. | Muscle soreness assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no soreness and 10 indicates maximal soreness. |
| Secondary | Perceived Recovery Status | Baseline, immediately post-exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise. | Recovery status assessed using the Perceived Recovery Status Scale (PRS), with higher scores indicating a greater subjective perception of recovery. |
| Secondary | Change in Thigh Circumference | Baseline, immediately after exercise, immediately after the intervention, 24 hours, 3 days, and 7 days after exercise. | Thigh circumference (cm) measured at a standardized anatomical location to evaluate potential changes associated with exercise-induced muscle damage and recovery. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892105
GET https://conductscience.org/api/trials/v1/NCT07892105/registered